April 4, 2016 – The Court issued a Memorandum and Order construing five disputed claim terms. The patent at issue is U.S. Patent No. 8,182,530, entitled “Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support.”
The case is pending in the District of Delaware and is captioned: Endoheart AG v. Edwards Lifesciences Corporation, DED-1-14-cv-01473.
By: David G. Varghese